Skip to content
Catalyst

1,7-dimethylxanthinePapers

Indexed under 1,7-dimethylxanthine in PubMed's chemical list

papers
104
41 years, by papers

Newest first

1 to 50 of 104
  • Caffeine metabolic phenotypes and hypertension risk: Urinary paraxanthine-to-caffeine ratio threshold and mediating pathways in NHANES.

    Nutrition, metabolism, and cardiovascular diseases2026PMID 41549015

  • Body fat percentage is a key factor in elevated plasma levels of caffeine and its metabolite in women.

    PeerJ2025PMID 40511376

  • Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run.

    Journal of the International Society of Sports Nutrition2024PMID 38725238

  • Simultaneous analysis of caffeine and paraxanthine provides potentially useful indexes in the treatment of acute caffeine intoxication.

    The Journal of toxicological sciences2024PMID 39358234

  • A purine derivative, paraxanthine, promotes cysteine uptake for glutathione synthesis.

    Journal of pharmacological sciences2023PMID 36522121

  • Maternal caffeine intake and DNA methylation in newborn cord blood.

    The American journal of clinical nutrition2022PMID 34669932

  • Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots.

    Clinical and translational science2022PMID 35338582

  • Caffeine, Paraxanthine, Theophylline, and Theobromine Content in Human Milk.

    Nutrients2022PMID 35683994

  • Determination of caffeine, paraxanthine, theophylline and theobromine in premature infants by HILIC-MS/MS.

    Bioanalysis2022PMID 36825935

  • Association Between Maternal Caffeine Consumption and Metabolism and Neonatal Anthropometry: A Secondary Analysis of the NICHD Fetal Growth Studies-Singletons.

    JAMA network open2021PMID 33764424

  • The determination of the Paraxanthine/Caffeine ratio as a metabolic biomarker for CYP1A2 activity in various human matrices by UHPLC-ESIMS/MS.

    Talanta2021PMID 34364467

  • Acute Paraxanthine Ingestion Improves Cognition and Short-Term Memory and Helps Sustain Attention in a Double-Blind, Placebo-Controlled, Crossover Trial.

    Nutrients2021PMID 34836235

  • Dose-Response of Paraxanthine on Cognitive Function: A Double Blind, Placebo Controlled, Crossover Trial.

    Nutrients2021PMID 34960030

  • Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers: A metabolomic study.

    Neurology2020PMID 32999056

  • Caffeine and paraxanthine in aquatic systems: Global exposure distributions and probabilistic risk assessment.

    The Science of the total environment2018PMID 28892846

  • Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.

    Journal of clinical pharmacology2016PMID 26358647

  • Establishing population distribution of drug-metabolizing enzyme activities for the use of salivary caffeine as a dynamic liver function marker in a Singaporean Chinese population.

    Biopharmaceutics & drug disposition2016PMID 26862045

  • Serum caffeine and paraxanthine concentrations and menstrual cycle function: correlations with beverage intakes and associations with race, reproductive hormones, and anovulation in the BioCycle Study.

    The American journal of clinical nutrition2016PMID 27225433

  • Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior.

    Human molecular genetics2016PMID 27702941

  • Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?

    Clinical pharmacokinetics2015PMID 25603821

  • Maternal serum paraxanthine during pregnancy and offspring body mass index at ages 4 and 7 years.

    Epidemiology (Cambridge, Mass.)2015PMID 25643099

  • Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake.

    The Journal of nutrition2015PMID 25833779

  • Analysis of caffeine and paraxanthine in human saliva with ultra-high-performance liquid chromatography for CYP1A2 phenotyping.

    Journal of chromatography2015PMID 26038236

  • Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study.

    Analytica chimica acta2015PMID 26041521

  • Simultaneous multiplexed quantification of caffeine and its major metabolites theobromine and paraxanthine using surface-enhanced Raman scattering.

    Analytical and bioanalytical chemistry2015PMID 26345445

  • Second-Trimester Maternal Serum Paraxanthine, CYP1A2 Activity, and the Risk of Severe Preeclampsia.

    Obstetrics and gynecology2015PMID 26348183

  • An optimized and validated SPE-LC-MS/MS method for the determination of caffeine and paraxanthine in hair.

    Talanta2015PMID 26452792

  • Maternal Caffeine Intake During Pregnancy and Child Cognition and Behavior at 4 and 7 Years of Age.

    American journal of epidemiology2015PMID 26585526

  • The effect of single- and multiple-dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects.

    Journal of clinical pharmacology2014PMID 24165884

  • Comparison of maternal and fetal blood levels of caffeine and its metabolite. A pilot study.

    Ginekologia polska2014PMID 25118500

  • Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans.

    Neuropharmacology2013PMID 23261866

  • High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.

    Journal of chromatography2012PMID 22483397

  • Measurement of CYP1A2 activity: a focus on caffeine as a probe.

    Current drug metabolism2012PMID 22554278

  • Changes in CYP1A2 activity in humans after 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) administration using caffeine as a probe drug.

    Drug metabolism and pharmacokinetics2012PMID 22673010

  • Pharmacokinetics and metabolism of natural methylxanthines in animal and man.

    Handbook of experimental pharmacology2011PMID 20859793

  • Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.

    The Journal of pharmacy and pharmacology2011PMID 21827488

  • Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice.

    Sleep2010PMID 20614853

  • Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.

    Biomedical chromatography2010PMID 20853468

  • Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population.

    Pharmacogenomics2009PMID 19450128

  • Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.

    Xenobiotica; the fate of foreign compounds in biological systems2009PMID 19534587

  • Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine.

    European journal of clinical pharmacology2008PMID 17955229

  • Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects.

    Clinical pharmacokinetics2008PMID 18076219

  • Assessing caffeine exposure in pregnant women.

    The British journal of nutrition2008PMID 18331663

  • In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.

    Biomedical chromatography2007PMID 17221922

  • Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach.

    Clinical pharmacology and therapeutics2007PMID 17259951

  • Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction.

    American journal of epidemiology2006PMID 16641310

  • Awareness and use of caffeine by athletes competing at the 2005 Ironman Triathlon World Championships.

    International journal of sport nutrition and exercise metabolism2006PMID 17240785

  • Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.

    Basic & clinical pharmacology & toxicology2005PMID 15667599

  • Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans.

    Drug metabolism and disposition: the biological fate of chemicals2005PMID 15980104

  • Assessment of CYP1A2 activity in clinical practice: why, how, and when?

    Basic & clinical pharmacology & toxicology2005PMID 16128905

The next 50 papers

Every paper about 1,7-dimethylxanthine